GlassScriptPhysician profile
Surya P Rao
NPI 1114975596
$36,432.18
in general payments reported to CMS, 2019-2025
46 companies · $9,756 in 2025
The $9,756 reported for 2025 was more than what 94% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,955 · 2020: $714 · 2021: $2,982 · 2022: $3,759 · 2023: $15K · 2024: $2,506 · 2025: $9,756.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $10K · Consulting Fee: $6,778 · Food and Beverage: $5,874 · Travel and Lodging: $4,372.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $10,000.00 |
| Consulting Fee | $6,778.00 |
| Food and Beverage | $5,873.58 |
| Travel and Lodging | $4,371.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $10,234.55 | 2022-2025 | Assure Wcd |
| Impulse Dynamics (USA) INC. | $9,367.71 | 2021-2025 | Optimizer, Optimizer |
| Abbott Laboratories | $6,169.10 | 2019-2025 | Aveir, Amplatzer Amulet, Freestyle Libre 3 |
| Cvrx, INC. | $3,166.52 | 2019-2025 | Barostim Neo System |
| Medtronic, INC. | $1,130.33 | 2021-2025 | Evera Mri Xt Dr Surescan, Micra, Hawkone |
| Boston Scientific Corporation | $975.10 | 2019-2025 | Avvigo Guidance System, Synergy, Lux-Dx Insertable Cardiac Monitor |
| Janssen Pharmaceuticals, INC | $738.62 | 2019-2024 | Xarelto |
| Merck Sharp & Dohme LLC | $575.52 | 2021-2025 | Verquvo |
| Abiomed | $432.82 | 2019-2025 | Impella |
| Astrazeneca Pharmaceuticals LP | $343.93 | 2019-2022 | |
| Cardiovascular Systems INC. | $338.45 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $337.97 | 2019-2024 | |
| Amgen INC. | $305.33 | 2019-2025 | Repatha |
| Penumbra, INC. | $289.93 | 2021-2024 | Indigo System |
| Biotronik INC. | $277.70 | 2021-2022 |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acist Medical Systems, INC. | $259.66 | 2019-2021 | |
| Elutia, INC. | $152.61 | 2022-2025 | Ecm Patch,Pouch |
| E.R. Squibb & Sons, L.L.C. | $149.26 | 2019-2025 | Camzyos, Eliquis |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $133.64 | 2019-2025 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $126.34 | 2019-2021 | |
| Medtronic Vascular, INC. | $95.86 | 2019-2020 | |
| Stryker Corporation | $70.77 | 2025 | Flowtriever |
| Inari Medical, INC. | $67.34 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Pfizer INC. | $66.72 | 2019-2024 | |
| Esperion Therapeutics, INC. | $62.68 | 2020-2021 | |
| Bracco Diagnostics INC. | $59.85 | 2025 | |
| Teleflex LLC | $45.55 | 2019 | |
| Bard Peripheral Vascular, INC. | $39.88 | 2022 | |
| Novo Nordisk INC | $39.49 | 2021-2022 | |
| Bardy Diagnostics, INC. | $37.50 | 2020-2021 | |
| Atricure, INC. | $30.54 | 2025 | Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System |
| G Medical Diagnostic Services, INC. | $30.25 | 2020-2021 | |
| Cleerly, INC. | $29.49 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Edwards Lifesciences Corporation | $26.10 | 2019 | |
| Daiichi Sankyo INC. | $25.75 | 2024 | Injectafer |
| Kiniksa Pharmaceuticals, LTD. | $24.81 | 2023 | Arcalyst |
| Medicomp INC | $24.29 | 2023 | Telepatch Cardiac Monitor |
| Convatec INC. | $23.51 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $22.51 | 2025 | |
| Sanofi-Aventis U.S. LLC | $19.01 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $18.37 | 2019 | |
| Shockwave Medical, INC | $18.29 | 2022 | |
| Angiodynamics, INC. | $17.39 | 2022 | |
| Cardiva Medical, INC. | $16.48 | 2023 | Cardiva Vascade 6/7f Vcs |
| Kowa Pharmaceuticals America, INC. | $14.66 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Surya Rao listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.